Synlogic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Synlogic and buy or sell other stocks, ETFs, and their options commission-free!About SYBX
Synlogic, Inc. engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs.
CEOAoife M. Brennan
CEOAoife M. Brennan
Employees72
Employees72
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2017
Founded2017
Employees72
Employees72
SYBX Key Statistics
Market cap43.60M
Market cap43.60M
Price-Earnings ratio-0.30
Price-Earnings ratio-0.30
Dividend yield—
Dividend yield—
Average volume380.50K
Average volume380.50K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.35
52 Week high$1.35
52 Week low$0.234
52 Week low$0.234
Stock Snapshot
As of today, Synlogic(SYBX) shares are valued at $0.64. The company's market cap stands at 43.6M, with a P/E ratio of -0.30.
On 2026-04-14, Synlogic(SYBX) stock opened at —, reached a high of —, and a low of —.
Synlogic(SYBX) shares are trading with a volume of 0, against a daily average of 380.5K.
During the past year, Synlogic(SYBX) stock moved between $0.23 at its lowest and $1.35 at its peak.
During the past year, Synlogic(SYBX) stock moved between $0.23 at its lowest and $1.35 at its peak.
People also own
Based on the portfolios of people who own SYBX. This list is generated using Robinhood data, and it’s not a recommendation.